Dr Yiming Shao

Dr Yiming Shao graduated from Qingdao Medical School in 1983 and got his doctor degree on virology and immunology from Chinese Academy of Preventive Medicine in 1988. Dr. Shao is currently Chief Expert on AIDS, Chinese Center for Disease Control and Prevention and Director of the Division of Research on Virology and Immunology at the National Center for AIDS/STD Control and Prevention. He serves as vice chairs of both the National AIDS Expert Committee and Chinese Microbiology Society. He is member of the Chinese People’s Political Consultative Conference (China’s Parliament Upper House) since 2003 and has been playing roles in coordinating biomedical and policy research on infectious disease control, public health as well as promoting international research collaboration at national level

He is credited with establishing the National AIDS Reference Laboratory and leading the national expert committee to help develop three national infrastructures: the five-level HIV testing network, HIV molecular epidemiology network, and HIV drug resistance surveillance network. His group first reported China’s nationwide HIV molecular epidemiology and HIV drug resistance profile. He and Dr Shen, who made the world’s 1st lentivirus vaccine in the 1970s, systematically studied the genetic evolution of EIAV wide-type to vaccine strains and its protection mechanisms. He leads the research on re-designing HIV vaccine antigen based on EIAV vaccine and using Chinese replicating vaccinia vector to develop a China CDC’s HIV vaccine program. The vaccine can provide full and partial protection against viral acquisition from homologous and heterologous SHIV challenge respectively in monkeys. The vaccine have concluded phase Ia, Ib, Ic and phase IIa clinical trials in both low and high risk populations and is moving to Phase II b trial in China.

Internationally, he is member of the International Committee on Taxonomy of Viruses and serves on the WHO's AIDS Strategic and Technical Advisory Committee, HIVResNet Steering Committee, and HIV Vaccine Advisory committee. He received numerous national science awards and published more than 500 research papers in scientific journals, including over 160 papers in SCI journals. He was elected as the fellow of the US Academy of Microbiology in 2010.